◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Leveljump Healthcare Corp.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 4.8M 4.7M 4.6M 4.8M 4.4M --
Operating Revenue 4.8M 4.7M 4.6M 4.8M 4.4M --
Cost Of Revenue 3.9M 3.7M 3.5M 3.9M 3.6M --
Gross Profit 937,505 963,528 1.1M 900,444 877,489 --
Selling General And Administration 236,487 248,868 283,612 850,659 229,667 --
General And Administrative Expense 236,487 248,868 283,612 809,792 229,667 --
Depreciation And Amortization In Income Statement 49,248 49,248 49,248 49,247 43,103 --
Other Operating Expenses 387,874 583,076 480,859 9,083 370,768 --
Operating Expense 673,609 881,192 813,719 908,989 643,538 --
Operating Income 263,896 82,336 278,342 -8,545 233,951 --
EBIT 220,379 77,669 499,873 54,184 249,268 --
Interest Expense 224,181 229,216 299,307 312,812 254,688 --
Interest Expense Non Operating 224,181 229,216 299,307 312,812 254,688 --
Net Interest Income -224,181 -229,216 -299,307 -334,118 -254,688 --
Other Income Expense -43,517 -4,667 221,531 84,035 15,317 --
Other Non Operating Income Expenses -43,517 -4,667 221,531 81,226 15,317 --
Special Income Charges -- -- -- 2,809 0.00 0.00
Gain On Sale Of Security -- -- -- 0.00 -- 98,130
Pretax Income -3,802 -151,547 200,566 -258,628 -5,420 --
Tax Provision 22,575 -18,402 0.00 -2.2M 0.00 --
Tax Effect Of Unusual Items 0.00 0.00 0.00 421.35 0.00 --
Net Income From Continuing And Discontinued Operation -26,378 -133,145 200,566 2.0M -5,421 --
Net Income From Continuing Operation Net Minority Interest -26,378 -133,145 200,566 2.0M -5,421 --
Net Income Including Noncontrolling Interests -26,377 -133,145 200,566 2.0M -5,420 --
Net Income Common Stockholders -26,378 -133,145 200,566 2.0M -5,421 --
Net Income -26,378 -133,145 200,566 2.0M -5,421 --
EBITDA 577,740 299,559 898,017 196,307 711,243 --
Normalized EBITDA 577,740 299,559 898,017 193,498 711,243 --
Reconciled Depreciation 357,361 221,890 398,144 142,123 461,975 --
Basic EPS 0.00 -0.00 0.00 -- 0.00 -0.00
Diluted EPS 0.00 -0.00 0.00 -- 0.00 -0.00
Basic Average Shares 96.5M 96.5M 96.5M -- 96.5M 96.5M
Diluted Average Shares 96.5M 96.5M 109.9M -- 96.5M 96.5M
Total Unusual Items -- -- -- 2,809 0.00 98,130
Total Unusual Items Excluding Goodwill -- -- -- 2,809 0.00 98,130
Tax Rate For Calcs 0.15 0.12 0.00 0.15 0.00 --
Normalized Income -26,378 -133,145 200,566 1.9M -5,421 --
Average Dilution Earnings -- 128,640 128,640 -- -- 64,320
Depreciation Amortization Depletion Income Statement 49,248 49,248 49,248 49,247 43,103 --
Diluted NI Availto Com Stockholders -26,378 -4,505 329,206 2.0M -5,421 --
Gain On Sale Of Ppe -- -- -- 2,809 0.00 0.00
Insurance And Claims -- -- -- 17,444 10,285 19,171
Net Income Continuous Operations -26,377 -133,145 200,566 2.0M -5,420 --
Net Non Operating Interest Income Expense -224,181 -229,216 -299,307 -334,118 -254,688 --
Other Gand A 236,487 248,868 283,612 665,698 229,667 --
Reconciled Cost Of Revenue 3.6M 3.6M 3.1M 3.8M 3.2M --
Salaries And Wages -- -- -- 126,650 136,996 25,571
Total Expenses 4.6M 4.6M 4.3M 4.8M 4.2M --
Total Operating Income As Reported 263,896 82,336 278,342 -- 233,951 128,078
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 111,508 234,592 -1,809 52,600 1,422 --
Cash Cash Equivalents And Short Term Investments 111,508 234,592 -1,809 52,600 1,422 --
Cash Financial 111,508 234,592 -1,809 52,600 1,422 --
Accounts Receivable 1.2M 1.1M 1.3M 1.4M 1.1M --
Receivables 3.1M 2.8M 2.9M 3.0M 2.7M --
Prepaid Assets 151,364 163,263 150,270 138,592 199,517 --
Other Current Assets -1.00 1.00 1.00 -- -- --
Current Assets 3.3M 3.2M 3.0M 3.2M 2.9M --
Gross PPE 6.3M 6.7M 6.6M 7.1M 7.2M --
Accumulated Depreciation -- -- -- -1.2M -1.4M -775,193
Net PPE 6.3M 6.7M 6.6M 5.9M 5.8M --
Goodwill -- -- -- 3.7M 3.7M 3.5M
Goodwill And Other Intangible Assets 9.9M 9.9M 9.9M 9.9M 9.9M --
Other Intangible Assets -- -- -- 6.2M 6.2M 6.2M
Investments And Advances -- -- -- 0.00 0.00 0.00
Long Term Equity Investment -- -- -- -- 0.00 0.00
Other Non Current Assets -- -- -- -1.00 -- --
Total Non Current Assets 18.5M 18.9M 18.7M 18.0M 15.7M --
Total Assets 21.8M 22.1M 21.8M 21.2M 18.6M --
Current Debt 1.6M 1.6M 1.6M 1.6M 1.1M --
Current Debt And Capital Lease Obligation 2.2M 2.2M 2.7M 2.7M 1.6M --
Accounts Payable 3.7M 3.6M 3.3M 3.4M 3.1M --
Payables 3.7M 3.6M 3.7M 3.8M 3.4M --
Payables And Accrued Expenses 3.8M 3.7M 3.8M 3.8M 3.5M --
Current Accrued Expenses 83,040 43,769 45,982 29,697 91,156 --
Other Current Liabilities -- -- 1.00 -- 1.00 --
Current Liabilities 5.9M 5.9M 6.5M 6.5M 5.1M --
Long Term Debt 5.4M 5.6M 5.8M 5.9M 6.1M --
Long Term Debt And Capital Lease Obligation 7.1M 7.4M 6.8M 6.3M 7.1M --
Long Term Capital Lease Obligation 1.7M 1.8M 990,382 402,615 1.0M --
Other Non Current Liabilities -- -1.00 -1.00 222,327 222,327 222,326
Total Non Current Liabilities Net Minority Interest 9.5M 9.8M 8.7M 8.4M 9.2M --
Total Liabilities Net Minority Interest 15.5M 15.7M 15.2M 14.9M 14.3M --
Common Stock 16.2M 16.2M 16.2M 16.2M 16.2M --
Capital Stock 16.3M 16.3M 16.3M 16.3M 16.2M --
Additional Paid In Capital 5.6M 5.6M 5.6M 5.6M 5.5M --
Retained Earnings -15.5M -15.5M -15.3M -15.5M -17.5M --
Common Stock Equity 6.3M 6.3M 6.5M 6.3M 4.3M --
Stockholders Equity 6.3M 6.4M 6.6M 6.4M 4.3M --
Total Equity Gross Minority Interest 6.3M 6.4M 6.6M 6.4M 4.3M --
Total Capitalization 11.7M 12.0M 12.4M 12.3M 10.4M --
Net Tangible Assets -3.6M -3.5M -3.3M -3.5M -5.6M --
Tangible Book Value -3.6M -3.6M -3.5M -3.6M -5.6M --
Working Capital -2.6M -2.6M -3.4M -3.3M -2.2M --
Invested Capital 13.3M 13.5M 13.9M 13.7M 11.5M --
Total Debt 9.3M 9.6M 9.5M 9.0M 8.8M --
Net Debt 6.9M 7.0M 7.5M 7.4M 7.2M --
Share Issued 96.5M 96.5M 96.5M 96.5M 96.5M --
Ordinary Shares Number 96.5M 96.5M 96.5M 96.5M 96.5M --
Buildings And Improvements 2.2M 2.3M 2.0M 1.4M -- --
Capital Lease Obligations 2.3M 2.4M 2.1M 1.5M 1.6M --
Current Capital Lease Obligation 554,972 554,972 1.1M 1.1M 557,789 --
Dividends Payable -- -- 413,340 284,700 284,700 220,380
Duefrom Related Parties Current 1.8M 1.6M 1.5M 1.6M 1.5M --
Financial Assets Designatedas Fair Value Through Profitor Loss Total -- -- -- 0.00 -- --
Income Tax Payable 2,703 26,633 59,003 59,003 -- --
Investmentin Financial Assets -- -- -- 0.00 -- --
Investmentsin Associatesat Cost -- -- -- -- 0.00 0.00
Leases -- -- -- 3.2M 3.2M 3.0M
Line Of Credit 655,309 651,286 650,783 642,288 148,952 --
Machinery Furniture Equipment -- -- -- 265,636 262,716 265,635
Non Current Deferred Assets 2.3M 2.3M 2.3M 2.3M -- --
Non Current Deferred Taxes Assets 2.3M 2.3M 2.3M 2.3M -- --
Other Current Borrowings 980,218 982,461 966,906 935,249 935,249 --
Other Properties 4.2M 4.4M 4.6M 2.2M 3.7M --
Preferred Securities Outside Stock Equity 2.5M 2.4M 1.9M 1.9M 1.8M --
Preferred Stock 87,859 96,484 105,109 105,109 -- --
Preferred Stock Equity 87,859 96,484 105,109 105,109 -- --
Properties 0.00 0.00 0.00 0.00 0.00 --
Taxes Receivable 0.00 30,769 61,551 61,551 -- --
Total Tax Payable 2,703 26,633 59,003 59,003 -- --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow 409,884 829,413 573,068 262,541 516,457 --
Cash Flow From Continuing Operating Activities 457,780 829,413 573,068 262,540 516,457 --
Depreciation And Amortization 357,361 221,890 398,144 142,123 461,975 --
Depreciation Amortization Depletion 357,361 221,890 398,144 142,123 461,975 --
Stock Based Compensation 0.00 0.00 0.00 43,100 37,100 --
Change In Working Capital 58,209 672,080 -100,462 99,533 -41,517 --
Changes In Account Receivables -- 210,607 48,678 -273,773 157,426 -104,257
Change In Receivables -- 210,607 48,678 -273,773 157,426 -104,257
Change In Payables And Accrued Expense 58,209 461,473 -149,140 377,064 -198,943 --
Change In Payable -- -- -149,140 -- -- --
Other Non Cash Items 139,513 191,677 227,256 814,711 64,320 --
Capital Expenditure -26,495 -217,844 -397,657 -153,787 -246,556 --
Purchase Of PPE -26,495 -217,844 -371,197 -170,081 -236,471 --
Net PPE Purchase And Sale -26,495 -217,844 -371,197 -170,081 -236,471 --
Sale Of Business -- -- -- -- 0.00 --
Sale Of Investment 0.00 0.00 0.00 -- 0.00 784,000
Net Investment Purchase And Sale 0.00 0.00 0.00 -- 0.00 784,000
Investing Cash Flow -26,495 -217,844 -326,782 -1.0M -246,556 --
Cash Flow From Continuing Investing Activities -26,495 -217,844 -326,782 -1.0M -246,556 --
Issuance Of Debt 0.00 4,197 212,065 -- 0.00 0.00
Repayment Of Debt -339,585 -241,437 -512,760 -1.2M -300,463 --
Net Issuance Payments Of Debt -339,585 -237,240 -300,695 -42,971 -300,463 --
Issuance Of Capital Stock 18,232 18,232 0.00 -6,000 0.00 --
Repurchase Of Capital Stock -- -8,625 -- -- -- 0.00
Net Common Stock Issuance -8,625 -8,625 0.00 -6,000 0.00 --
Common Stock Payments -- -8,625 -- -- -- 0.00
Financing Cash Flow -506,474 -375,168 -300,695 807,501 -527,920 --
Cash Flow From Continuing Financing Activities -506,473 -375,167 -300,695 807,501 -527,920 --
Changes In Cash -123,084 236,401 -54,410 51,178 -258,019 --
Beginning Cash Position 234,592 -1,809 52,600 1,422 259,441 --
End Cash Position 111,508 234,592 -1,810 52,600 1,422 --
Free Cash Flow 383,389 611,569 175,411 108,754 269,901 --
Capital Expenditure Reported 0.00 0.00 -26,460 -- -- --
Change In Account Payable -- -- -149,140 -- -- --
Change In Accrued Expense -- -- -- -- -- -72,385
Change In Prepaid Assets -- -- -- -- 0.00 34,345
Common Stock Issuance -- -- 0.00 -6,000 0.00 0.00
Depreciation 357,361 221,890 398,144 142,123 461,975 --
Earnings Losses From Equity Investments 4,268 -- -- -- 0.00 --
Gain Loss On Sale Of PPE -- -- -- -- -- 0.00
Interest Paid Cfo -123,089 -123,089 -152,436 -468,578 -37,021 --
Long Term Debt Issuance 0.00 4,197 212,065 -- 0.00 0.00
Long Term Debt Payments -339,585 -241,437 -512,760 -1.2M -300,463 --
Net Business Purchase And Sale -- -- -- -1.1M 0.00 --
Net Foreign Currency Exchange Gain Loss -- -- -- -- -- 0.00
Net Income From Continuing Operations -26,378 -133,145 200,566 2.0M -5,421 --
Net Intangibles Purchase And Sale 0.00 0.00 0.00 22,792 -10,085 --
Net Long Term Debt Issuance -339,585 -237,240 -300,695 -536,576 -300,463 --
Net Other Financing Charges -176,496 -147,535 -- -- -227,457 -155,710
Net Other Investing Changes -- -- 70,875 -- -- -138,121
Net Preferred Stock Issuance 18,232 18,232 -- -- 0.00 0.00
Operating Gains Losses 4,268 -- -- -- -- --
Preferred Stock Issuance 18,232 18,232 -- -- 0.00 0.00
Preferred Stock Payments -- -- -- -- -- 0.00
Purchase Of Intangibles 0.00 0.00 0.00 22,792 -10,085 --
Unrealized Gain Loss On Investment Securities -- -- -- -- -- 0.00
NEWS
Loading news...
TRENDING
Loading...